Skip to content

Protein Supplementation and Muscle Recovery in Football

Effect of Milk Protein Supplementation on Muscle Recovery and Football-specific Performance During an In-season Microcycle With Two Matches

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03348267
Acronym
PRO-FOOTBALL
Enrollment
20
Registered
2017-11-20
Start date
2016-05-01
Completion date
2016-09-15
Last updated
2018-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skeletal Muscle Damage, Muscle Inflammation, Muscle Recovery, Soccer Performance

Brief summary

Soccer is an intermittent sport including a high number of powerful actions such as accelerations, decelerations, changes of direction, jumps and impacts that incorporate a strong eccentric component and may therefore lead to skeletal muscle damage. Indeed, match activity is associated with the onset of muscle damage and an acute inflammatory response that result in attenuated performance for as long as 1 to 3 days. In competitive soccer though, multiple matches are performed within a small-time frame resulting in inadequate muscle recovery and reduced field performance. Supplementation with milk proteins following intense exercise protocols has been shown to stimulate protein synthesis and facilitate muscle recovery. Thus, the aim of the present investigation is to examine the effects of milk protein supplementation on muscle recovery and soccer-specific performance during an in-season microcycle with two matches performed three days apart.

Detailed description

In a double-blind, cross over, repeated measures design 20 men soccer players will receive either placebo (PLA) or milk protein isolate (PRO, 80% casein-20% whey) throughout recovery following two matches performed three days apart. On match days, players will receive a dose immediately after the match (PLA vs PRO: 25g of protein) and then at 3h (PLA vs PRO: 30g of protein) and 6h (PLA vs PRO: 25g of protein) post-match. On each day of the remaining days, players will consume a single dose of PLA or PRO (20g of protein) with breakfast. All players will participate in regular in-season training following matches. Field activity during both matches and daily practices will be monitored using GPS devices. Heart rate will be continuously recorded during each match and training session. Blood samples will be collected at baseline as well as 2 hours after the first match, daily for three days after the first match, 2 hours after the second match and daily for 3 days after the second match. Performance (isokinetic strength, 20-m speed, repeated sprint ability) and muscle soreness will be assessed at baseline daily for 3 days after both matches. Muscle biopsies from vastus lateralis will be collected at baseline and one day after each match.

Interventions

DIETARY_SUPPLEMENTMilk protein isolate

Milk protein isolate in a powder form consisted of 80% casein and 20% whey protein. 20g were diluted into 500 ml water

DIETARY_SUPPLEMENTPlacebo

500 mL drink that contained water (375 mL), sugar-free cordial (125 mL) and 2 g of low-calorie glucose/dextrose powder.

Sponsors

University of Thessaly
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* i) participation at elite level (top three division leagues) of soccer competition for at least five years, ii) abstain from consumption of performance-enhancing supplements, antioxidant supplements and medications (for at least 6 months before and during the study), iv) participate in at least six two-hour training sessions per week and played at least one match per week and v) non-smokers.

Exclusion criteria

* i) a known milk intolerance or allergy, ii) a recent febrile illness, iii) history of muscle lesion, iv) lower limb trauma and v) metabolic diseases.

Design outcomes

Primary

MeasureTime frameDescription
Change in heart rateDuring Match 1 and Match 2Heart rate will be continuously recorded during both matches using the Team Polar system.
Change in countermovement jumpAt baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2Countermovement jump will be assessed on a contact platform
Change in isokinetic strength of lower limbsAt baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2Isokinetic strength will be assessed on an isokinetic dynamometer for both knee extensors and knee flexors at 120 and 180 degrees.
Change in match activityDuring Match 1 and Match 2Match activity will be continuously recorded during both matches using GPS technology.
Change in creatine kinase in plasmaAt baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2Concentration of creatine kinase will be measured in plasma
Change in uric acid in plasmaAt baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2Concentration of uric acid will be measured in plasma
Change in protein carbonyls in bloodAt baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2Concentration of protein carbonyls will be measured in red blood cells
Change in total antioxidant capacityAt baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2Total antioxidant capacity will be measured in plasma
Change in reduced glutathione in bloodAt baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2Concentration of reduced glutathione will be measured in in red blood cells
Change in oxidized glutathione in bloodAt baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2Concentration of oxidized glutathione will be measured in red blood cells
Change in malondialdehyde in bloodAt baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2Concentration of malondialdehyde will be measured in serum
Change in catalase activityAt baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2Catalase activity will be measured in red blood cells
Change in protein carbonyls in muscleAt baseline, 24h post-Match 1 and 24h post-Match 2Concentration of protein carbonyls will be measured in muscle
Change in intracellular signaling proteins in muscleAt baseline, 24h post-Match 1 and 24h post-Match 2Phosphorylation levels of Akt, mammalian target of rapamycin (mTOR) and p70S6K will be measure using western blotting.
Change in proteasome activities in muscleAt baseline, 24h post-Match 1 and 24h post-Match 2Chymotrypsin-like (CT-L), caspase-like (C-L) and trypsin-like (T-L) proteasome activities will be assayed with hydrolysis of the fluorogenic peptide LLVY-AMC, LLE-AMC and LSTR-AMC, respectively.
Change in satellite cells in muscleAt baseline, 24h post-Match 1 and 24h post-Match 2Pax7, Myf5, MyoD and Myogenin will be measured in order to quantify quiescent, activated, proliferated-differentiated and fused satellite cells respectively.
Change in repeated Sprint AbilityAt baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 25 x 30 m sprints will be performed with 25 seconds rest in-between. Mean time for 5 sprints and fatigue index will be calculated.

Secondary

MeasureTime frameDescription
Dietary intakeOver a 7-day period at baseline.Dietary intake will be assessed using 7-day diet recalls.
Change in white blood cell count.At baseline, immediately after Match 1, at 24h, 48h and 72h post-Match 1 as well as immediately after Match 2 and at 24h, 48h and 72h post-Match 2.White blood cell count will be measured using an automatic blood analyzer.
Change in delayed onset of muscle sorenessAt baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2Muscle soreness will assessed during palpation of the muscle belly and the distal region of relaxed vastus medialis, vastus lateralis and rectus femoris following three repetitions of of a full squat. Subjects will rate their DOMS on a visual analogue scale (0-10).

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026